Literature DB >> 28400710

Update on the Use of Consensus Interferon in Difficult-to-Treat Hepatitis C Patients: A Review of Selected Posters From Digestive Disease Week May 20-25, 2006 Los Angeles, Calif.With commentary by:Fred Poordad, MDCedars-Sinai Medical CenterLos Angeles, Calif.

.   

Abstract

Entities:  

Year:  2006        PMID： 28400710      PMCID： PMC5382910     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  19 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.

Authors:  M J Tong; K R Reddy; W M Lee; P J Pockros; J C Hoefs; E B Keeffe; F B Hollinger; E J Hathcote; H White; R T Foust; D M Jensen; E L Krawitt; H Fromm; M Black; L M Blatt; M Klein; J Lubina
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

3.  Re-treatment of chronic hepatitis C with consensus interferon .

Authors:  E J Heathcote; E B Keeffe; S S Lee; S V Feinman; M J Tong; K R Reddy; D G Albert; K Witt; L M Blatt
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 6.  The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon.

Authors:  L M Blatt; J M Davis; S B Klein; M W Taylor
Journal:  J Interferon Cytokine Res       Date:  1996-07       Impact factor: 2.607

7.  High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C.

Authors:  David N Moskovitz; Pooma Manoharan; E Jenny Heathcote
Journal:  Can J Gastroenterol       Date:  2003-08       Impact factor: 3.522

8.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

9.  Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

Authors:  Lennox J Jeffers; William Cassidy; Charles D Howell; Sylvia Hu; K Rajender Reddy
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.

Authors:  Andrew J Muir; Jeffrey D Bornstein; Paul G Killenberg
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.